Rubric Capital Management LP
NEW YORK, NY
$10.9bn in 86 US stocks at the end of 30 June 2026. The top 10 are 46.4% of the money. It changed about 20.9% of the portfolio this quarter.
Value
$10.9bn
Stocks
86
Top 10 share
46.4%
Turnover
20.9%
What changed this quarter
New
Bought for the first time this quarter.
- FluorFLR2.4% of the fund
- Amazon.comAMZN2.0% of the fund
- Sonoco ProductsSON0.6% of the fund
- StubHub HoldingsSTUB0.6% of the fund
- Galaxy DigitalGLXY0.6% of the fund
- Establishment Labs HoldingsESTA0.5% of the fund
- AlvotechALVO0.5% of the fund
- VersigentVGNT0.3% of the fund
- TripAdvisorTRIP0.3% of the fund
- BiohavenBHVN0.2% of the fund
- ANI PharmaceuticalsANIP0.2% of the fund
- uniQureQURE0.2% of the fund
- Hudson Pacific PropertiesHPP0.1% of the fund
- GDS HldgsGDS0.1% of the fund
- OmerosOMER<0.1% of the fund
- Abeona TherapeuticsABEO<0.1% of the fund
- Tetra TechnologiesTTI<0.1% of the fund
- Service Properties TrustSVC<0.1% of the fund
Added
Bought more of a stock they already held.
- FTAI AviationFTAI7.4% of the fund+16%
- Teva Pharmaceutical IndustriesTEVA4.8% of the fund+2%
- VistraVST2.6% of the fund+20%
- TransaltaTAC2.6% of the fund+14%
- Kiniksa Pharmaceuticals InternationalKNSA2.3% of the fund+7%
- BGC GroupBGC2.3% of the fund+2%
- Zoom CommunicationsZM2.2% of the fund+176%
- Gildan ActivewearGIL2.1% of the fund+222%
- Roivant SciencesROIV1.9% of the fund+20%
- AmcorAMCR1.7% of the fund+228%
- CimpressCMPR1.6% of the fund+7%
- Nurix TherapeuticsNRIX1.6% of the fund+192%
- PennyMac Financial ServicesPFSI1.4% of the fund+3006%
- MeiraGTx HoldingsMGTX1.1% of the fund+30%
- GEO GroupGEO1.1% of the fund+10%
- SchrodingerSDGR1.0% of the fund+7%
- CompassCOMP0.9% of the fund+119%
- Newell BrandsNWL0.9% of the fund+5%
- CoreCivicCXW0.8% of the fund+38%
- ArdelyxARDX0.8% of the fund+771%
- EnovisENOV0.7% of the fund+59%
- Adma BiologicsADMA0.7% of the fund+416%
- MannkindMNKD0.7% of the fund+397%
- Driven Brands HoldingsDRVN0.7% of the fund+77%
- Mission ProduceAVO0.6% of the fund+246%
Cut
Sold some of their stake.
- Amneal PharmaceuticalsAMRX1.6% of the fund-8%
- Mercury GeneralMCY1.5% of the fund-28%
- EcovystECVT0.9% of the fund-10%
- Edgewell Personal CareEPC0.9% of the fund-11%
- AdeiaADEA0.6% of the fund-50%
- Primo BrandsPRMB0.6% of the fund-4%
- Trevi TherapeuticsTRVI0.4% of the fund-33%
- Proto LabsPRLB<0.1% of the fund-78%
- Edesa BiotechEDSA<0.1% of the fund-3%
- CartersCRI<0.1% of the fund-91%
Sold out
Sold their entire stake.
- Constellation EnergyCEG-100%
- Akamai TechnologiesAKAM-100%
- Telephone & Data SystemsTDS-100%
- Protagonist TherapeuticsPTGX-100%
- Calavo Growers-100%
- TelesatTSAT-100%
- Biomarin PharmaceuticalBMRN-100%
- Indivior PharmaceuticalsINDV-100%
- Acadia Healthcare CompanyACHC-100%
- Capri HoldingsCPRI-100%
- EmbectaEMBC-100%
- Helen of TroyHELE-100%
- PlaystudiosMYPS-100%
Holdings
- TransaltaTAC
- Share
- 2.6%
- Value
- $280m
- Shares
- 20,232,011
+14%
- Gildan ActivewearGIL
- Share
- 2.1%
- Value
- $232m
- Shares
- 4,500,000
+222%
- VersigentVGNT
- Share
- 0.3%
- Value
- $36m
- Shares
- 855,163
New
- GDS HldgsGDS
- Share
- 0.1%
- Value
- $15m
- Shares
- 485,873
New
- Grupo Aeromexico SAB de CVAERO
- Share
- <0.1%
- Value
- $8m
- Shares
- 467,129
Held
- Eupraxia PharmaceuticalsEPRX
- Share
- <0.1%
- Value
- $6m
- Shares
- 867,424
+26%
- Mereo Biopharma GroupMREO
- Share
- <0.1%
- Value
- $5m
- Shares
- 15,307,347
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Talen EnergyTLN | 12.7% | $1.4bn | 3,602,171 | Held |
| FTAI AviationFTAI | 7.4% | $812m | 3,000,000 | +16% |
| ViatrisVTRS | 5.0% | $543m | 34,168,743 | Held |
| Teva Pharmaceutical IndustriesTEVA | 4.8% | $528m | 15,575,000 | +2% |
| Golar LNGGLNG | 4.2% | $457m | 9,178,978 | Held |
| VistraVST | 2.6% | $285m | 1,794,953 | +20% |
| TransaltaTAC | 2.6% | $280m | 20,232,011 | +14% |
| FluorFLR | 2.4% | $263m | 5,017,248 | New |
| Kiniksa Pharmaceuticals InternationalKNSA | 2.3% | $256m | 3,999,800 | +7% |
| BGC GroupBGC | 2.3% | $254m | 23,800,000 | +2% |
| Zoom CommunicationsZM | 2.2% | $239m | 2,766,009 | +176% |
| Gildan ActivewearGIL | 2.1% | $232m | 4,500,000 | +222% |
| Arcutis BiotherapeuticsARQT | 2.0% | $217m | 8,271,577 | Held |
| Amazon.comAMZN | 2.0% | $215m | 900,000 | New |
| Roivant SciencesROIV | 1.9% | $212m | 6,000,000 | +20% |
| ZymeworksZYME | 1.7% | $183m | 7,000,000 | Held |
| AmcorAMCR | 1.7% | $180m | 4,162,030 | +228% |
| CimpressCMPR | 1.6% | $178m | 1,750,000 | +7% |
| Amneal PharmaceuticalsAMRX | 1.6% | $176m | 10,168,660 | -8% |
| Nurix TherapeuticsNRIX | 1.6% | $175m | 7,227,778 | +192% |
| Mercury GeneralMCY | 1.5% | $164m | 1,541,440 | -28% |
| PennyMac Financial ServicesPFSI | 1.4% | $148m | 1,700,000 | +3006% |
| Integra Lifesciences HoldingsIART | 1.3% | $139m | 7,753,934 | Held |
| Delek US HoldingsDK | 1.3% | $137m | 2,687,449 | Held |
| Liberty GlobalLBTYA | 1.2% | $134m | 11,752,855 | Held |
| MeiraGTx HoldingsMGTX | 1.1% | $123m | 9,100,000 | +30% |
| GEO GroupGEO | 1.1% | $122m | 4,131,219 | +10% |
| Liberty Latin AmericaLILAK | 1.1% | $122m | 15,645,430 | Held |
| SchrodingerSDGR | 1.0% | $104m | 6,400,000 | +7% |
| EcovystECVT | 0.9% | $102m | 8,211,888 | -10% |
| Liberty GlobalLBTYK | 0.9% | $102m | 9,259,361 | Held |
| CompassCOMP | 0.9% | $101m | 8,218,394 | +119% |
| Newell BrandsNWL | 0.9% | $98m | 16,000,000 | +5% |
| Edgewell Personal CareEPC | 0.9% | $95m | 3,544,465 | -11% |
| CoreCivicCXW | 0.8% | $87m | 2,847,436 | +38% |
| ArdelyxARDX | 0.8% | $83m | 16,202,700 | +771% |
| EnovisENOV | 0.7% | $81m | 3,900,000 | +59% |
| Adma BiologicsADMA | 0.7% | $78m | 9,339,414 | +416% |
| MannkindMNKD | 0.7% | $77m | 18,000,000 | +397% |
| Driven Brands HoldingsDRVN | 0.7% | $74m | 5,300,613 | +77% |
| Opko HealthOPK | 0.7% | $72m | 47,791,243 | Held |
| Mission ProduceAVO | 0.6% | $71m | 5,981,953 | +246% |
| AdeiaADEA | 0.6% | $70m | 2,126,633 | -50% |
| ReNew Energy GlobalRNW | 0.6% | $69m | 11,000,000 | Held |
| StratasysSSYS | 0.6% | $68m | 8,000,000 | Held |
| ARS PharmaceuticalsSPRY | 0.6% | $68m | 8,540,861 | +7% |
| AndersonsANDE | 0.6% | $68m | 999,559 | +17% |
| Primo BrandsPRMB | 0.6% | $65m | 2,672,231 | -4% |
| Sonoco ProductsSON | 0.6% | $64m | 1,143,562 | New |
| StubHub HoldingsSTUB | 0.6% | $64m | 5,000,000 | New |
| Galaxy DigitalGLXY | 0.6% | $64m | 2,343,169 | New |
| Venture GlobalVG | 0.6% | $60m | 5,410,280 | +261% |
| Establishment Labs HoldingsESTA | 0.5% | $59m | 688,325 | New |
| QuidelOrthoQDEL | 0.5% | $58m | 3,306,281 | Held |
| AlvotechALVO | 0.5% | $58m | 15,677,093 | New |
| Target HospitalityTH | 0.5% | $53m | 2,586,389 | +18% |
| DnowDNOW | 0.5% | $51m | 3,898,635 | +208% |
| Prothena Corp PublicPRTA | 0.4% | $49m | 5,000,000 | Held |
| Trevi TherapeuticsTRVI | 0.4% | $47m | 2,504,513 | -33% |
| Collegium PharmaceuticalCOLL | 0.4% | $46m | 1,279,611 | Held |
| Arbutus BiopharmaABUS | 0.3% | $36m | 7,532,937 | +14% |
| VersigentVGNT | 0.3% | $36m | 855,163 | New |
| XperiXPER | 0.3% | $34m | 4,143,744 | Held |
| Orthofix MedicalOFIX | 0.3% | $34m | 3,721,715 | Held |
| TripAdvisorTRIP | 0.3% | $33m | 2,439,110 | New |
| Mativ HoldingsMATV | 0.3% | $30m | 3,982,442 | Held |
| Liberty Latin AmericaLILA | 0.3% | $30m | 3,777,654 | Held |
| BiohavenBHVN | 0.2% | $26m | 1,721,493 | New |
| Vistance NetworksVISN | 0.2% | $26m | 2,000,000 | Held |
| ANI PharmaceuticalsANIP | 0.2% | $21m | 258,131 | New |
| uniQureQURE | 0.2% | $19m | 408,581 | New |
| Hudson Pacific PropertiesHPP | 0.1% | $15m | 1,019,598 | New |
| Seaport Entertainment GroupSEG | 0.1% | $15m | 568,530 | Held |
| GDS HldgsGDS | 0.1% | $15m | 485,873 | New |
| Heron TherapeuticsHRTX | 0.1% | $13m | 30,046,828 | Held |
| Proto LabsPRLB | <0.1% | $9m | 108,692 | -78% |
| Grupo Aeromexico SAB de CVAERO | <0.1% | $8m | 467,129 | Held |
| OmerosOMER | <0.1% | $6m | 656,874 | New |
| Eupraxia PharmaceuticalsEPRX | <0.1% | $6m | 867,424 | +26% |
| Edesa BiotechEDSA | <0.1% | $5m | 669,500 | -3% |
| Mereo Biopharma GroupMREO | <0.1% | $5m | 15,307,347 | Held |
| Abeona TherapeuticsABEO | <0.1% | $4m | 608,771 | New |
| CartersCRI | <0.1% | $4m | 86,844 | -91% |
| TherapeuticsMDTXMD | <0.1% | $3m | 1,192,191 | Held |
| Tetra TechnologiesTTI | <0.1% | $2m | 150,000 | New |
| Service Properties TrustSVC | <0.1% | $2m | 900,000 | New |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 75.3% since 30 June 2025.
Where the money is
Health care33.1%
Utilities19.1%
Technology11.1%
Industrials9.4%
Retail & consumer7.5%
Financial services5.8%
Materials5.2%
Media & telecom4.2%
Real estate1.9%
Energy1.3%
Everyday goods1.2%
Other0.3%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.